Compare Pulau Subur Tbk. (PTPS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pulau Subur Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Pulau Subur Tbk. trades at Rp165 (market cap 359.81B, 2.22M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Pulau Subur Tbk. is far larger — about 3.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PTPS | SCPI | |
|---|---|---|
Market Cap | 359.81B | 104.4B |
Volume | 2.22M | — |
Lot | 22.22K | — |
Turnover | 366.22M | — |
Average Price | 164.84 | — |
Value | 366.22M | — |
Indicative Equilibrium Price | 165 | — |
Indicative Equilibrium Volume | 417 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pulau Subur Tbk.
PT Pulau Subur Tbk (the Company) was established based on Deed No. 1 of October 1, 1980 by Justin AR, S.H., notary in Palembang. The Company started its commercial operations in October 1980. PT Sekawan Kontrindo, is the parent entity of the Company. The ultimate shareholders of the Company is Mr. Abunawar.
Read more on PTPS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
